US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

登録

ホーム
投資
株式
アメリカ
NASDAQ
Point Therapeutics (MM) (POTP)
Point Therapeutics (MM) (POTP) ニュース

POTP

Point Therapeutics (MM) (POTP)

Point Therapeutics (MM)

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:POTP

1 2 3 4 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2008/02/13	06 : 15	PR Newswire (US)	DARA BioSciences, Inc. and Point Therapeutics, Inc. Announce Consummation of Merger	NASDAQ:POTP	Point Therapeutics (MM)
2008/02/13	05 : 02	Edgar (US Regulatory)	Point Therapeutics Inc - Amended Statement of Ownership (SC 13G/A)	NASDAQ:POTP	Point Therapeutics (MM)
2008/02/12	04 : 30	Edgar (US Regulatory)	Point Therapeutics Inc - Current report filing (8-K)	NASDAQ:POTP	Point Therapeutics (MM)
2008/02/11	23 : 00	Business Wire	Update on Point Therapeutics Merger with DARA BioSciences	NASDAQ:POTP	Point Therapeutics (MM)
2008/02/09	00 : 23	Edgar (US Regulatory)	Point Therapeutics Inc-Filing of certain prospectuses & communications for business combination transactions (425)	NASDAQ:POTP	Point Therapeutics (MM)
2008/02/04	22 : 36	Edgar (US Regulatory)	Point Therapeutics Inc-Filing of certain prospectuses & communications for business combination transactions (425)	NASDAQ:POTP	Point Therapeutics (MM)
2008/02/04	21 : 30	PR Newswire (US)	DARA BioSciences to Present at the ROTH Growth Stock Conference	NASDAQ:POTP	Point Therapeutics (MM)
2008/01/30	06 : 30	Business Wire	Point Therapeutics Adjourns Meeting of Stockholders to February 12, 2008; DARA BioSciences Stockholders Approve Merger with Poin	NASDAQ:POTP	Point Therapeutics (MM)
2008/01/17	20 : 03	Edgar (US Regulatory)	Point Therapeutics Inc-Filing of certain prospectuses & communications for business combination transactions (425)	NASDAQ:POTP	Point Therapeutics (MM)
2008/01/11	04 : 07	Edgar (US Regulatory)	Point Therapeutics Inc - Current report filing (8-K)	NASDAQ:POTP	Point Therapeutics (MM)
2008/01/10	22 : 00	Business Wire	Point Therapeutics Receives Additional Notice of Non-Compliance from NASDAQ	NASDAQ:POTP	Point Therapeutics (MM)
2007/12/28	05 : 45	Edgar (US Regulatory)	Point Therapeutics Inc - Current report filing (8-K)	NASDAQ:POTP	Point Therapeutics (MM)
2007/12/28	05 : 43	Edgar (US Regulatory)	Point Therapeutics Inc-Filing of certain prospectuses & communications for business combination transactions (425)	NASDAQ:POTP	Point Therapeutics (MM)
2007/12/27	22 : 30	Business Wire	Point Therapeutics Announces Form S-4 Registration Statement Declared Effective by SEC; Special Meeting of Stockholders Set for	NASDAQ:POTP	Point Therapeutics (MM)
2007/12/19	02 : 55	Edgar (US Regulatory)	Point Therapeutics Inc - Current report filing (8-K)	NASDAQ:POTP	Point Therapeutics (MM)
2007/12/18	07 : 12	Edgar (US Regulatory)	Point Therapeutics Inc - Registration Statement for securities to be issued in business combination transactions (S-4/A)	NASDAQ:POTP	Point Therapeutics (MM)
2007/12/18	03 : 17	Edgar (US Regulatory)	Point Therapeutics Inc - Current report filing (8-K)	NASDAQ:POTP	Point Therapeutics (MM)
2007/12/17	22 : 30	Business Wire	NASDAQ Panel Grants Request of Point Therapeutics for Continued Listing on NASDAQ Capital Market	NASDAQ:POTP	Point Therapeutics (MM)
2007/11/26	21 : 13	Edgar (US Regulatory)	Point Therapeutics Inc - Securities Registration: Business Combination (S-4)	NASDAQ:POTP	Point Therapeutics (MM)
2007/11/20	02 : 36	Edgar (US Regulatory)	Point Therapeutics Inc - Current report filing (8-K)	NASDAQ:POTP	Point Therapeutics (MM)
2007/11/09	23 : 59	Edgar (US Regulatory)	Point Therapeutics Inc - Current report filing (8-K)	NASDAQ:POTP	Point Therapeutics (MM)
2007/11/09	23 : 38	Edgar (US Regulatory)	Point Therapeutics Inc - Quarterly Report (10-Q)	NASDAQ:POTP	Point Therapeutics (MM)
2007/10/25	20 : 00	PR Newswire (US)	DARA BioSciences, Inc. Announces New Board Chairman	NASDAQ:POTP	Point Therapeutics (MM)
2007/10/17	20 : 00	PR Newswire (US)	DARA BioSciences and Bayer Pharmaceuticals Corporation Sign Exclusive License Agreement	NASDAQ:POTP	Point Therapeutics (MM)
2007/09/19	04 : 36	Edgar (US Regulatory)	Point Therapeutics Inc - Current report filing (8-K)	NASDAQ:POTP	Point Therapeutics (MM)
2007/08/10	05 : 01	Business Wire	Point Therapeutics Reports Second Quarter 2007 Financial Results	NASDAQ:POTP	Point Therapeutics (MM)
2007/07/27	20 : 30	Business Wire	Point Therapeutics Announces Further Management Reductions	NASDAQ:POTP	Point Therapeutics (MM)
2007/07/12	21 : 30	Business Wire	Point Therapeutics Update	NASDAQ:POTP	Point Therapeutics (MM)
2007/05/31	21 : 00	Business Wire	Point Therapeutics Reduces Costs by Cutting Work Force	NASDAQ:POTP	Point Therapeutics (MM)
2007/05/21	21 : 00	Business Wire	Talabostat Clinical Program Put on Clinical Hold by FDA	NASDAQ:POTP	Point Therapeutics (MM)

Showing the most relevant articles for your search:NASDAQ:POTP

1 2 3 4 次へ >>

UBS Lux Fund Sol - BBG E...

Managed Support Services

Tecnicas Reunidas (PK)

Vontobel Financial Produ...

Societe Generale Effekten

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約